These are valid and understandable concerns, Ryan explains
From what I can tell, the best described mechanism for hair loss related to these novel weight loss agents is a telogen effluvium mechanism
This is potentially dangerous and almost certainly counterproductive
A JAMA Network Open retrospective cohort study of 125,474 adults with overweight or obesity: Patients with T2DM: 46.5% discontinued by year one 64.1% discontinued by year two Patients without T2DM: 64.8% discontinued by year one 84.4% discontinued by year two Nearly 85% of patients without diabetes stopped taking GLP-1s within two years
She emphasizes listening to the patient, treating systemic contributors, and combining targeted tools with foundational lifestyle work
But it may not be tasty, either, Collingwood notes